BIOMAT Database Logo BIOMAT Database Logo

HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. 1999

V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy.
May 1999, American family physician,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
[HIV: no virus eradication with HAART. Highly active antiretroviral therapy].
February 2000, Deutsche medizinische Wochenschrift (1946),
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
[Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
January 2002, Przeglad epidemiologiczny,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
[Correlation between CD4 T-cell counts and HIV-1 RNA plasma levels in HIV-1 patients receiving highly active antiretroviral therapy (HAART)]
January 1999, Le infezioni in medicina,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (HAART).
July 2015, Journal of clinical and diagnostic research : JCDR,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
[Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
May 2004, Recenti progressi in medicina,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia.
December 2013, Global journal of health science,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy.
January 2000, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil.
January 2008, Journal of public health dentistry,
V Natarajan, and M Bosche, and J A Metcalf, and D J Ward, and H C Lane, and J A Kovacs
HIV and HAART in 1997. Highly active antiretroviral therapy.
August 1997, The Nurse practitioner,
Copied contents to your clipboard!